Indwelling urinary catheters are commonly used in the management of 25 hospitalized patients. Candida can adhere to the device surface and propagate 26 as a biofilm. These communities differ from free-floating Candida, exhibiting high 27 tolerance to antifungal therapy.
tolerance to antifungal therapy.
The significance of catheter-associated 28 candiduria is often unclear and treatment may be problematic considering the 29 biofilm drug resistant phenotype. Here we describe a rodent model for study of 30 urinary catheter-associated Candida albicans biofilm infection that mimics this 31 common process in patients. In the setting of a functioning, indwelling urinary 32 catheter in a rat, Candida proliferated as a biofilm on the device surface. 
INTRODUCTION

MATERIALS AND METHODS 92
Organisms and inoculum. Candida albicans strains K1, DAY185, and als1-/-93 als3-/-were used for studies (17) (18) (19) . The strains were stored in 15% (vol/vol) 94 glycerol stock at -80 o C and maintained on yeast extract-peptone-dextrose (YPD) 95 medium + uridine (1% yeast extract, 2% peptone, 2% dextrose, and 80 μg/ml 96 uridine) prior to experiments. Prior to catheter inoculation, cells were grown at 97
30
o C in YPD + uridine liquid media with orbital shaking at 200 RPM overnight. 98
To prepare inoculum, cells were enumerated by hemocytometer counting and 99 resuspended in YDP at 10 8 cells/ml. Final inoculum concentration was confirmed 100 by microbiologic enumeration. 101 hole in the lid and secured with a bolt and washer. Recovery of the animal after 138 the catheter surgery was assessed according to a standard protocol approved by 139 the Veterans Administration Animal Committee. After 24-72 hours, the animals 140 were euthanized and catheters and/or bladders were collected for analysis, as 141 described below. 142
143
Fungal cultures and urinalysis. To determine the viable burden of C. albicans, 144 microbiologic counts were performed on urine, urinary catheters, and bladders. 145
Urinary catheters were placed in 2 ml 0.15M NaCl, sonicated for 10 min (FS 1% osmium tetroxide buffered with PBS for 30 min, and rinsed with PBS. The 158 samples were subsequently dehydrated with a series of ethanol washes (30% for 159 10 min, 50% for 10 min, 70% for 10 min, 95% for 10 min, and 100% for 10 min) 160 and desiccation was performed by critical-point drying (Tousimis, Rockville, Md.) . 161
Specimens were mounted on aluminum stubs and sputter coated with gold. 162
Samples were imaged in a scanning electron microscope (SEM LEO 1530) at 3 163 kV. The images were processed for display using Adobe Photoshop. 164
165
Histopathology. To evaluate the host response to C. albicans infection of the 166 urinary catheter, we examined bladder wall histopathology. Animals were 167 sacrificed at 48 hours. The urinary catheters were removed and bladders were 168 dissected, fixed in 10% buffered formalin, and embedded in paraffin (20) . 169
Sections were stained with hematoxylin and eosin (H&E) and Gomori's 170 methenamine silver (GMS) for imaging of Candida. Images were obtained at 10x 171 and 40x. For SEM, bladders were fixed in phosphate buffered 1.5% 172 glutaraldehyde solution and otherwise processed and imaged for SEM as 173 described above. 174
175
Antifungal treatments. The effect of antifungal therapy on viable C. albicans 176 biofilms was assessed by systemic treatment of mature biofilm infections (24h 177 incubation) for 2 days. Animals were treated with either fluconazole 25 mg/kg 178 subcutaneously once daily or amphotericin B deoxycholate 1 mg/kg 179 intraperitoneally once daily and compared to untreated controls. At the 180 completion of therapy, animals were sacrificed. The catheters and bladders were 181 removed and the viable Candida burden was determined as described above. 182
Microbiologic assays were performed in triplicate and significant differences were 183 measured by ANOVA with pair-wise comparisons using the Holm-Sidak method. 184
185
RNA collection and quantitative RT-PCR. Urinary catheters were collected for 186
RT-PCR analysis after 24 hours of growth and placed in RNA later (Qiagen) . 187
Biofilm cells were dislodged from the catheter by vortexing, and sonication. RNA 188 was purified using the RNeasy Minikit (Qiagen) and quantified using a NanoDrop 189 spectrophotometer. TaqMan primer and probe sets designed using Primer 190
Express (Applied Biosystems, Foster City, CA) for ACT1, FKS1, BGL2, XOG1, 191 and PHR1 were used as previously described (Supplementary Table 1 
/-).
We next sought to test the ability of the model to detect the phenotype of a 292
Candida strain with a biofilm deficient phenotype. We chose the als1-/-als3-/-293 mutant, which lacks two adhesins important for C. albicans adherence and 294 biofilm formation in vitro and in an in vivo vascular catheter model (33). We 295 hypothesized that the mutant would also exhibit a biofilm defect in the rat urinary 296 catheter niche. Compared to an otherwise isogenic reference strain, the als1-/-297 als3-/-urinary catheter biofilm was composed of nearly 100 fold fewer cells on 298 viable burden testing ( Figure 7B) . As theorized based on prior biofilm studies, 299 these adhesins appear to play a critical role in biofilm formation in the urine 300 environment and this is detectable the rat urinary catheter model. 301
302
DISCUSSION 303
In the presence of an artificial substrate, Candida transitions to a biofilm lifestyle, 304 engaging with the surface and proliferating as an adherent community (34-37). concentrations, a relatively low pH, creatinine, and urea (47, 48). Similar to the 330 current investigation, biofilms formed under these conditions exhibited resistance 331 to antifungals commonly used to treat urinary tract infections, including 332 amphotericin B and fluconazole. However, compared to control biofilms growing 333 in RPMI media, biofilms produced under the synthetic urine media condition were 334 less dense and fewer cells had transitioned to the hyphal state. This is in contrast 335 to the current investigation, where hyphae were prominent in the C. albicans 336 biofilms on the luminal urinary catheter surface (Figure 3) . Interestingly, the 337 antifungal therapy was effective against the tissue associated Candida in the 338 model suggesting the presence of both biofilm and non-biofilm cells in the model. was not surprising, given the role to these pathways in extracellular matrix 355 production and biofilm drug resistance (21, 43). We found have similarities 356 between our current study and our prior microarray analysis which compared rat 357 vascular catheter biofilms to planktonic controls (51). For example, transcripts of 358 β-1,3 glucan synthase, FKS1, were more abundant in the catheter biofilms 359 (vascular 1.8-fold, urinary 1.3 fold). Likewise, 1,3-beta-glucosyltransferase, 360 BGL2, was upregulated in both catheter models (vascular 1.5-3.1-fold, urinary 361 3.7-fold), as were glucanosyltransferase, PHR1, (vascular 2.4-24.2-fold, urinary 362 3.3-fold) and beta glucosidase, XOG1, (vascular 1.7-fold, urinary 1.9-fold). In a 363 rat denture model of C. albicans biofilm formation, BGL2 was similarly 364 upregulated (1.6-fold) compared to planktonic controls (24). These findings 365 suggest there are conserved pathways among the various clinical biofilm niches. As a method to predispose to Candida infection, mice deficient in lysozyme M 381 production, an important effector for mucosal innate immunity, were utilized. The 382 advantages of the model include the smaller animal size of the mouse and the 383 ability to include the defined murine genotypes, such as the lysozyme M deficient 384
mouse. 385
One limitation of the previously described rodent CAUTI models is the placement 386 of the catheter segments (53-55). Although the catheter segments are exposed 387 to urine and host components in the bladder, the catheters lack a uretheral 388 component and do not function to drain the urinary system, as would be the case 389 for patient catheters. Without a urethral component, the catheters lack flow, one 390 of the key factors influencing biofilm architecture and extracellular matrix 391 production (56-58). To best account for physiologic flow in the current studies, we 392 utilized urethral catheters that functioned to drain urine from the bladder 393 throughout the course of the experiments. Not only did this have the advantage 394 of mimicking flow, but also permitted repeated collection of urine samples. 395
396
To most closely mimic a patient infection, we chose to use a silicone urinary 397 catheter, as this is the most common urinary catheter material (59). Biofilms 398 formed on the luminal surface over the several days following intraluminal 399 inoculation. However, on SEM, the biofilms were observed to often be dislodged 400 or peeling from the catheter surface (Figure 3) . This is in contrast to what has 401 been observed in prior CAUTI model of C. albicans infection and a rat venous 402 catheter biofilm infection, both of which had used polyethylene catheters (17, 55) . 403
We suspect the dehydration process required for SEM altered the silicone, 404 weakening the biofilm binding. Another possibility is that urinary biofilms are less 405 adherent to the device due to unique environmental conditions in the urine. We 406 favor the former hypothesis given clinical descriptions of extensive biofilm in the 407 literature and our demonstration of a large infectious burden by microbiological 408 counts. The viable plate count method was also useful for assessment of 409 antifungal drug effect and the impact of various genetic mutants on urinary 410 biofilm formation (Figure 7 ). Using this model we identified histopathologic 411 changes consistent with acute cystitis (Figure 4) . This is similar to descriptions 412 from other animal models of bacterial CAUTI (52, 55). On specific fungal staining, 413 mucosal invasion by Candida was evident and reminiscent of denture biofilm Candida biofilm infection may be of interest to identify pathways either unique to 436 individual clinical niches or conserved among diverse clinical biofilms (17, 24, 25, 437 32, 55, 60, 64, 65 C. albicans burden in a rat urinary catheter biofilm. Urine was collected from 666 a rat following C. albicans infection of an implanted urinary catheter after 24, 48, 667 and 72 hours of growth and microbiological counts were used to determine the 668 number of organisms present in the biofilms (A). Urinary catheters from 2 rats 669 were harvested after 48 h of biofilm growth and adherent Candida were 670 enumerated (B). 671
Figure 3 672
Scanning electron microscopy (SEM) images of a C. albicans urinary 673 denture biofilm. Intact urinary catheter C. albicans biofilms were harvested 674 after 48 h of growth, processed for SEM, and imaged. Scale bars for 100x and 675 1500x images represent 250 μm and 10 μm, respectively. Arrows point to areas 676 of extracellular matrix. The arrow head denotes an area with hyphae and yeast. 677
678
Figure 4 679
Bladder histopathology for C. albicans urinary catheter biofilm infection. . 680
Rat urinary catheters were infected with C. albicans. After 48 h, animals were 681 sacrificed and dissected samples were fixed. Sections were stained with 682 hematoxylin and eosin (H&E) and for C. albicans with Gomori's methenamine 683 silver (GMS). Images were obtained at 10x and 40x. The outline box of the 10x 684 images marks the approximate location where the 40x image was obtained. 685 686
Figure 5 687
Bladder SEM for C. albicans urinary catheter biofilm infection. Rat urinary 688 catheters were infected with C. albicans. After 48 h, animals were sacrificed and 689 dissected samples were processed for SEM and imaged. Scale bars represent 690 400 µm and 20 µm for 50x and 1000x images, respectively. Arrows point to 691 
